Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sawai Urges Japan To Take 'Best And Only Chance' To Reform Pricing Amid Generic Crisis

Jul 08 2022

• By Lisa Takagi

Kenzo Sawai, president of Sawai Pharmaceutical answered to Scrip's exclusive interview on 22 Jun, 2022 — Kenzo Sawai, president of Sawai Pharmaceutical • Source: Lisa Takagi

Related Content

Nichi-Iko Offers Heartfelt Apology As It Forecasts Huge Annual Loss

Nov 26 2021

Nichi-Iko Aims To Regroup As It Enters Turnaround Process

May 25 2022

A Year's Struggle: How Japan Is Recovering Damaged Generic Supplies After Quality Violations

Apr 12 2022

Related Companies

Sawai Pharmaceutical Co., Ltd.

Nichi-Iko Pharmaceutical Co., Ltd.

Choseido Pharmaceutical Co. Ltd.

Additional Topics

Japan Asia Pacific Generic Drugs Strategy Supply Chain Pricing Strategies Policy BioPharmaceutical

More from Generics

More from Products

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window